By Rachel McArthur 04:04 am January 21, 2021
Vaccines by six developers – Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute) – are the ones doing the rounds in the region. Here’s what’s known about them.
By Rachel McArthur 04:03 am January 21, 2021
There are four main types of vaccines currently approved, in approval or being considered in the MENA region in its fight against COVID-19. We bring you a summary of just what they are, how they differ, along with the advantages and disadvantages of each type.
By Rachel McArthur 03:02 am December 29, 2020
Developed and managed by Pure Health, the Ministry of Health and Prevention’s Riayati aims to provide a centralised medical record for “every citizen and resident” in the Gulf country.
By Rachel McArthur 08:17 am December 16, 2020
Launched in partnership with the UAE capital’s Department of Health, the platform will use “advanced artificial intelligence analytic technologies such as machine learning” to assess various risk factors.
By Rachel McArthur 10:06 am December 10, 2020
The country’s Ministry of Health and Prevention introduced the new system on the sidelines of GITEX Technology Week 2020 in Dubai.
By Rachel McArthur 08:18 am December 09, 2020
Solutions include its medical supplies management system, training platforms, and new additions and updates to its mobile app.
By Rachel McArthur 06:18 am December 07, 2020
One of the country’s leading private healthcare providers took gold at the latest edition of the MENA Digital Awards for its conversational AI-powered agent.
By Rachel McArthur 08:41 am November 26, 2020
The healthcare provider – and first member of the Kingdom’s Mayo Clinic Care Network – will roll-out the EMR system in its Jeddah hospital and clinics.
By Rachel McArthur 10:55 am November 11, 2020
Both will work together to accelerate the growth of transformational healthcare companies across markets in the Middle East and North African, and the Association of South-East Asian Nations.
By Rachel McArthur 01:51 am September 16, 2020
Reportedly showing promising results is the G42 Healthcare vaccine currently undergoing Phase III clinical trials. It is now being made optionally available to healthcare professionals on the frontlines, confirmed the country’s Minister of Health and Prevention.
The Daily Brief Newsletter
Get daily news updates from Healthcare IT News.